BP
Boobalan Pachaiyappan Roth Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
16
Avg Return
Past Year
Past Year
63%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $3 |
337%
upside
| 1 | -4.7% |
0
%
| 10 Mar ‘26 3 months ago |
|
|
|
Buy
Initiated
| $3 |
33%
upside
| 1 | +20% |
0
%
| 11 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $16 |
225%
upside
| 3 | +69% |
0
%
| 19 Nov ‘25 6 months ago |
|
|
|
Buy
Maintained
| $9 |
93%
upside
| 3 | +13% |
0
%
| 13 Nov ‘25 7 months ago |
|
|
|
Buy
Maintained
| $13 |
51%
downside
| 3 | +112% |
0
%
| 12 Nov ‘25 7 months ago |
|
|
|
Buy
Initiated
| $62 |
15%
downside
| 1 | +76% |
0
%
| 17 Sep ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $3 |
752%
upside
| 1 | +367% |
0
%
| 18 Aug ‘25 10 months ago |
|
|
|
Buy
Maintained
| $3 |
280%
upside
| 1 | +31% |
0
%
| 15 Aug ‘25 10 months ago |
|
|
|
Buy
Maintained
| $6 |
243%
upside
| 1 | +69% |
0
%
| 13 Aug ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $16 |
545%
upside
| 2 | -25% |
0
%
| 12 Aug ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $116 |
9%
upside
| 1 | +15% |
0
%
| 18 Jun ‘25 12 months ago |
|